1. Zhukova E.M., Kolpakova T.А., Myshkova E.P., Reykhrud T.А. Experience of using bedaquiline in the integral treatment of the pulmonary tuberculosis patient with extensive drug resistance of M. tuberculosis. Tuberculosis and Lung Diseases, 2016, no. 10, pp. 62-66. (In Russ.)
2. Kofanov Yu.V., Doktorova N.P. Use of the new drug of bedaquiline in the therapy of drug resistant tuberculosis (a clinical case). Bulleten Meditsinskikh Internet Konferentsiy, 2015, vol. 5, no. 5, Available at: http://medconfer. com/node/5100 (In Russ.)
3. Morozova T.I., Otpuschennikova O.N., Doktorova N.P., Danilov А.N.Experience of using bedaquiline (Sirturo®) in the treatment of pulmonary tuberculosis patients with multiple drug resistance. Tuberculosis and Lung Diseases, 2016, no. 2, pp. 29-35. (In Russ.)
4. Edict no. 951 by RF MoH as of 29.19.2014 On Approval of Guidelines for Improvement of Respiratory Tuberculosis Diagnostics and Treatment. (In Russ.)
5. Federalnye klinicheskiye rekomendatsii po diagnostike i lecheniyu tuberkuleza organov dykhaniya s mnozhestvennoy i shirokoy lekarstennoy ustoichivostyu vozbuditelya. [Federal clinical recommendations for diagnosis and treatment of respiratory tuberculosis with multiple and extensive drug resistance]. (Vasilyeva I.A., Aksenova V.A., Ergeshov A.E., Maryandyshev A.O., Samoylova A.G., Bagdasaryan T.R., Komissarova O.G., Lovacheva O.V., Perfiliev A.V., Karpina N.L. et al.) Moscow, OOO NEW TERRA PUBL., 2014, 52 p.